MILLER VALUE PARTNERS, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 196 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
MILLER VALUE PARTNERS, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$355,000
+14.5%
20,0000.0%0.01%
+8.3%
Q3 2019$310,000
-9.9%
20,0000.0%0.01%
-7.7%
Q2 2019$344,000
+6.8%
20,0000.0%0.01%0.0%
Q1 2019$322,000
+9.9%
20,0000.0%0.01%0.0%
Q4 2018$293,000
-90.5%
20,000
-88.2%
0.01%
-87.0%
Q3 2018$3,089,000
+7.7%
170,0000.0%0.10%
-6.5%
Q2 2018$2,868,000
-13.9%
170,0000.0%0.11%
-23.0%
Q1 2018$3,330,000
-3.3%
170,0000.0%0.14%
-5.4%
Q4 2017$3,444,000
+16.6%
170,0000.0%0.15%
+15.7%
Q3 2017$2,953,000
-75.7%
170,000
-82.1%
0.13%
-74.3%
Q2 2017$12,176,000949,8000.49%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders